news

Press Releases

 
Press Releases
  Title and Summary View
PLEASANTON, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal second quarter ended April 30, 2016. Revenue increased 11% year-over-year to $483.8 million.  CooperVision (CVI) revenue up 9% to $391.2 million.  CooperSurgical (CSI) revenue up 23% to $92.6 million.GA...
PLEASANTON, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical has acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening. The transaction is valued at approximately $85 million and is expected to be neutral to earnings ...
PLEASANTON, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) will present at the William Blair Growth Stock Conference in Chicago, Illinois, on June 15, 2016. Greg W. Matz, Senior Vice President, Chief Financial Officer & Chief Risk Officer, will represent the Company in a presentation scheduled to begin at 10:20 AM ...
PLEASANTON, Calif., May 17, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that it will present at two upcoming financial conferences.  Albert G. White, III, Executive Vice President and Chief Strategy Officer, will represent the Company. The Jefferies Healthcare Conference in New York, NY on June 7, 2016 at 9...
PLEASANTON, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced it will release second quarter 2016 financial results on Thursday, June 2, 2016, at 4:15 PM ET.  Following the release, the Company will host a conference call at 5:00 PM ET to discuss the financial results and current corporate developments...
PLEASANTON, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's health care unit, has acquired Genesis Genetics, a genetics laboratory specializing in preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the in-vitro fertilizat...
PLEASANTON, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) announced the appointment of Colleen E. Jay and William A. Kozy to its Board of Directors, effective April 1, 2016. Ms. Jay is the President of the Beauty Specialty Business at Procter & Gamble, an American multinational consumer goods company. She h...
PLEASANTON, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- At its annual meeting held on Monday, March 14, 2016 in Pleasanton, California, the stockholders of The Cooper Companies, Inc. (NYSE:COO) elected seven directors, ratified the appointment of KPMG LLP as the Company's auditors for fiscal 2016 and approved the amendment and restatement of the 2...
PLEASANTON, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal first quarter ended January 31, 2016. First quarter revenue increased 1% year-over-year to $449.6 million.  First quarter GAAP earnings per share (EPS) $1.05, down 20 cents or 16% from last year's firs...
PLEASANTON, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced it will release first quarter 2016 financial results on Thursday, March 3, 2016, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the financial results and current corporate developments...
Page:
1
... NextLast
= add release to Briefcase